img

Global Molecular Diagnostics Raw Material Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Molecular Diagnostics Raw Material Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Due to the COVID-19 pandemic, the global Molecular Diagnostics Raw Material market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034. Fully considering the economic change by this health crisis, Reverse Transcriptase accounting for % of the Molecular Diagnostics Raw Material global market in 2024, is projected to value US$ million by 2034, growing at a revised % CAGR from 2023 to 2034. While Disease Diagnosis segment is altered to an % CAGR throughout this forecast period.
The global key companies of Molecular Diagnostics Raw Material include Thermo Fisher, Promega, Roche, Bio-Rad, Takara Bio, Agilent, Qiagen, Fapon Biotech and TOYOBO Biotech, etc. In 2024, the global top five players had a share approximately % in terms of revenue.
The United States Molecular Diagnostics Raw Material market size was US$ million in 2024, while China size was US$ million. The proportion of the United States was % in 2024, while China percentage was %, and it is predicted that China share will reach % in 2034, trailing a CAGR of % through the analysis period. As for the Europe Molecular Diagnostics Raw Material landscape, Germany is projected to reach US$ million by 2034. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Molecular Diagnostics Raw Material market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Molecular Diagnostics Raw Material market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Molecular Diagnostics Raw Material market. Readers of the report can become informed about current and future trends of the global Molecular Diagnostics Raw Material market and how they will impact market growth during the forecast period.



By Company


Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
TOYOBO Biotech
Vazyme
Fapon Biotech Inc
New England Biolabs
Segment by Type
Reverse Transcriptase
DNA Polymerase
PCR Excipients
Other

Segment by Application


Disease Diagnosis
Adjuvant Therapy
scientific Research
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2Revenue of Molecular Diagnostics Raw Material in global and regional level.
Chapter 3Detailed analysis of Molecular Diagnostics Raw Material companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9Latin America by type, by application and by country, revenue for each segment.
Chapter 10Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molecular Diagnostics Raw Material revenue, gross margin, and recent development, etc.
Chapter 12Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13Research Findings and Conclusion

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Raw Material Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Reverse Transcriptase
1.2.3 DNA Polymerase
1.2.4 PCR Excipients
1.2.5 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Raw Material Market Growth Rate by Application: 2018 VS 2024 VS 2034
1.3.2 Disease Diagnosis
1.3.3 Adjuvant Therapy
1.3.4 scientific Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Molecular Diagnostics Raw Material Market Size (2018-2034)
2.2 Molecular Diagnostics Raw Material Market Size across Key Geographies Worldwide: 2018 VS 2024 VS 2034
2.3 Global Molecular Diagnostics Raw Material Market Size by Region (2018-2023)
2.4 Global Molecular Diagnostics Raw Material Market Size Forecast by Region (2024-2034)
2.5 Global Top 10 Molecular Diagnostics Raw Material Countries Ranking by Market Size
3 Molecular Diagnostics Raw Material Competitive by Company
3.1 Global Molecular Diagnostics Raw Material Revenue by Players
3.1.1 Global Molecular Diagnostics Raw Material Revenue by Players (2018-2023)
3.1.2 Global Molecular Diagnostics Raw Material Market Share by Players (2018-2023)
3.2 Global Molecular Diagnostics Raw Material Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Molecular Diagnostics Raw Material Revenue
3.4 Global Molecular Diagnostics Raw Material Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Raw Material Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Raw Material Revenue in 2024
3.5 Global Key Players of Molecular Diagnostics Raw Material Head office and Area Served
3.6 Global Key Players of Molecular Diagnostics Raw Material, Product and Application
3.7 Global Key Players of Molecular Diagnostics Raw Material, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Molecular Diagnostics Raw Material Breakdown Data by Type
4.1 Global Molecular Diagnostics Raw Material Historic Revenue by Type (2018-2023)
4.2 Global Molecular Diagnostics Raw Material Forecasted Revenue by Type (2024-2034)
5 Global Molecular Diagnostics Raw Material Breakdown Data by Application
5.1 Global Molecular Diagnostics Raw Material Historic Market Size by Application (2018-2023)
5.2 Global Molecular Diagnostics Raw Material Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Molecular Diagnostics Raw Material Revenue by Company (2021-2023)
6.2 North America Molecular Diagnostics Raw Material Revenue by Type (2018-2034)
6.3 North America Molecular Diagnostics Raw Material Revenue by Application (2018-2034)
6.4 North America Molecular Diagnostics Raw Material Revenue by Country (2018-2034)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Molecular Diagnostics Raw Material Revenue by Company (2021-2023)
7.2 Europe Molecular Diagnostics Raw Material Revenue by Type (2018-2034)
7.3 Europe Molecular Diagnostics Raw Material Revenue by Application (2018-2034)
7.4 Europe Molecular Diagnostics Raw Material Revenue by Country (2018-2034)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Molecular Diagnostics Raw Material Revenue by Company (2021-2023)
8.2 Asia Pacific Molecular Diagnostics Raw Material Revenue by Type (2018-2034)
8.3 Asia Pacific Molecular Diagnostics Raw Material Revenue by Application (2018-2034)
8.4 Asia Pacific Molecular Diagnostics Raw Material Revenue by Region (2018-2034)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Molecular Diagnostics Raw Material Revenue by Company (2021-2023)
9.2 Latin America Molecular Diagnostics Raw Material Revenue by Type (2018-2034)
9.3 Latin America Molecular Diagnostics Raw Material Revenue by Application (2018-2034)
9.4 Latin America Molecular Diagnostics Raw Material Revenue by Country (2018-2034)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Molecular Diagnostics Raw Material Revenue by Company (2021-2023)
10.2 Middle East and Africa Molecular Diagnostics Raw Material Revenue by Type (2018-2034)
10.3 Middle East and Africa Molecular Diagnostics Raw Material Revenue by Application (2018-2034)
10.4 Middle East and Africa Molecular Diagnostics Raw Material Revenue by Country (2018-2034)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher Molecular Diagnostics Raw Material Products and Services
11.1.4 Thermo Fisher Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.1.5 Thermo Fisher Molecular Diagnostics Raw Material SWOT Analysis
11.1.6 Thermo Fisher Recent Development
11.2 Promega
11.2.1 Promega Company Details
11.2.2 Promega Business Overview
11.2.3 Promega Molecular Diagnostics Raw Material Products and Services
11.2.4 Promega Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.2.5 Promega Molecular Diagnostics Raw Material SWOT Analysis
11.2.6 Promega Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Molecular Diagnostics Raw Material Products and Services
11.3.4 Roche Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.3.5 Roche Molecular Diagnostics Raw Material SWOT Analysis
11.3.6 Roche Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad Molecular Diagnostics Raw Material Products and Services
11.4.4 Bio-Rad Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.4.5 Bio-Rad Molecular Diagnostics Raw Material SWOT Analysis
11.4.6 Bio-Rad Recent Development
11.5 Takara Bio
11.5.1 Takara Bio Company Details
11.5.2 Takara Bio Business Overview
11.5.3 Takara Bio Molecular Diagnostics Raw Material Products and Services
11.5.4 Takara Bio Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.5.5 Takara Bio Molecular Diagnostics Raw Material SWOT Analysis
11.5.6 Takara Bio Recent Development
11.6 Agilent
11.6.1 Agilent Company Details
11.6.2 Agilent Business Overview
11.6.3 Agilent Molecular Diagnostics Raw Material Products and Services
11.6.4 Agilent Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.6.5 Agilent Molecular Diagnostics Raw Material SWOT Analysis
11.6.6 Agilent Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Details
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Molecular Diagnostics Raw Material Products and Services
11.7.4 Qiagen Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.7.5 Qiagen Molecular Diagnostics Raw Material SWOT Analysis
11.7.6 Qiagen Recent Development
11.8 Fapon Biotech
11.8.1 Fapon Biotech Company Details
11.8.2 Fapon Biotech Business Overview
11.8.3 Fapon Biotech Molecular Diagnostics Raw Material Products and Services
11.8.4 Fapon Biotech Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.8.5 Fapon Biotech Molecular Diagnostics Raw Material SWOT Analysis
11.8.6 Fapon Biotech Recent Development
11.9 TOYOBO Biotech
11.9.1 TOYOBO Biotech Company Details
11.9.2 TOYOBO Biotech Business Overview
11.9.3 TOYOBO Biotech Molecular Diagnostics Raw Material Products and Services
11.9.4 TOYOBO Biotech Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.9.5 TOYOBO Biotech Molecular Diagnostics Raw Material SWOT Analysis
11.9.6 TOYOBO Biotech Recent Development
11.10 Vazyme
11.10.1 Vazyme Company Details
11.10.2 Vazyme Business Overview
11.10.3 Vazyme Molecular Diagnostics Raw Material Products and Services
11.10.4 Vazyme Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.10.5 Vazyme Molecular Diagnostics Raw Material SWOT Analysis
11.10.6 Vazyme Recent Development
11.11 Fapon Biotech Inc
11.11.1 Fapon Biotech Inc Company Details
11.11.2 Fapon Biotech Inc Business Overview
11.11.3 Fapon Biotech Inc Molecular Diagnostics Raw Material Products and Services
11.11.4 Fapon Biotech Inc Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.11.5 Fapon Biotech Inc Recent Development
11.12 New England Biolabs
11.12.1 New England Biolabs Company Details
11.12.2 New England Biolabs Business Overview
11.12.3 New England Biolabs Molecular Diagnostics Raw Material Products and Services
11.12.4 New England Biolabs Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023)
11.12.5 New England Biolabs Recent Development
12 Molecular Diagnostics Raw Material Market Dynamics
12.1 Molecular Diagnostics Raw Material Industry Trends
12.2 Molecular Diagnostics Raw Material Market Drivers
12.3 Molecular Diagnostics Raw Material Market Challenges
12.4 Molecular Diagnostics Raw Material Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Diagnostics Raw Material Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2024 VS 2034
Table 2. Key Players of Reverse Transcriptase
Table 3. Key Players of DNA Polymerase
Table 4. Key Players of PCR Excipients
Table 5. Key Players of Other
Table 6. Global Molecular Diagnostics Raw Material Market Size Growth Rate by Application (US$ Million), 2018 VS 2024 VS 2034
Table 7. Global Molecular Diagnostics Raw Material Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
Table 8. Global Molecular Diagnostics Raw Material Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Molecular Diagnostics Raw Material Revenue Forecast by Region (2024-2034) & (US$ Million)
Table 10. Global Molecular Diagnostics Raw Material Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Table 11. Global Molecular Diagnostics Raw Material Revenue by Players (2018-2023) & (US$ Million)
Table 12. Global Molecular Diagnostics Raw Material Market Share by Players (2018-2023)
Table 13. Global Top Molecular Diagnostics Raw Material Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Raw Material as of 2024)
Table 14. Ranking of Global Top Molecular Diagnostics Raw Material Companies by Revenue (US$ Million) in 2024
Table 15. Global 5 Largest Players Market Share by Molecular Diagnostics Raw Material Revenue (CR5 and HHI) & (2018-2023)
Table 16. Global Key Players of Molecular Diagnostics Raw Material, Headquarters and Area Served
Table 17. Global Key Players of Molecular Diagnostics Raw Material, Product and Application
Table 18. Global Key Players of Molecular Diagnostics Raw Material, Date of Enter into This Industry
Table 19. Mergers & Acquisitions, Expansion Plans
Table 20. Global Molecular Diagnostics Raw Material Market Size by Type (2018-2023) & (US$ Million)
Table 21. Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2023)
Table 22. Global Molecular Diagnostics Raw Material Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 23. Global Molecular Diagnostics Raw Material Revenue Market Share by Type (2024-2034)
Table 24. Global Molecular Diagnostics Raw Material Market Size by Application (2018-2023) & (US$ Million)
Table 25. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2023)
Table 26. Global Molecular Diagnostics Raw Material Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 27. Global Molecular Diagnostics Raw Material Revenue Market Share by Application (2024-2034)
Table 28. North America Molecular Diagnostics Raw Material Revenue by Company (2021-2023) & (US$ Million)
Table 29. North America Molecular Diagnostics Raw Material Revenue by Type (2018-2023) & (US$ Million)
Table 30. North America Molecular Diagnostics Raw Material Revenue by Type (2024-2034) & (US$ Million)
Table 31. North America Molecular Diagnostics Raw Material Revenue by Application (2018-2023) & (US$ Million)
Table 32. North America Molecular Diagnostics Raw Material Revenue by Application (2024-2034) & (US$ Million)
Table 33. North America Molecular Diagnostics Raw Material Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Molecular Diagnostics Raw Material Revenue by Country (2018-2023) & (US$ Million)
Table 35. North America Molecular Diagnostics Raw Material Revenue by Country (2024-2034) & (US$ Million)
Table 36. Europe Molecular Diagnostics Raw Material Revenue by Company (2021-2023) & (US$ Million)
Table 37. Europe Molecular Diagnostics Raw Material Revenue by Type (2018-2023) & (US$ Million)
Table 38. Europe Molecular Diagnostics Raw Material Revenue by Type (2024-2034) & (US$ Million)
Table 39. Europe Molecular Diagnostics Raw Material Revenue by Application (2018-2023) & (US$ Million)
Table 40. Europe Molecular Diagnostics Raw Material Revenue by Application (2024-2034) & (US$ Million)
Table 41. Europe Molecular Diagnostics Raw Material Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Europe Molecular Diagnostics Raw Material Revenue by Country (2018-2023) & (US$ Million)
Table 43. Europe Molecular Diagnostics Raw Material Revenue by Country (2024-2034) & (US$ Million)
Table 44. Asia Pacific Molecular Diagnostics Raw Material Revenue by Company (2021-2023) & (US$ Million)
Table 45. Asia Pacific Molecular Diagnostics Raw Material Revenue by Type (2018-2023) & (US$ Million)
Table 46. Asia Pacific Molecular Diagnostics Raw Material Revenue by Type (2024-2034) & (US$ Million)
Table 47. Asia Pacific Molecular Diagnostics Raw Material Revenue by Application (2018-2023) & (US$ Million)
Table 48. Asia Pacific Molecular Diagnostics Raw Material Revenue by Application (2024-2034) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnostics Raw Material Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 50. Asia Pacific Molecular Diagnostics Raw Material Revenue by Region (2018-2023) & (US$ Million)
Table 51. Asia Pacific Molecular Diagnostics Raw Material Revenue by Region (2024-2034) & (US$ Million)
Table 52. Latin America Molecular Diagnostics Raw Material Revenue by Company (2021-2023) & (US$ Million)
Table 53. Latin America Molecular Diagnostics Raw Material Revenue by Type (2018-2023) & (US$ Million)
Table 54. Latin America Molecular Diagnostics Raw Material Revenue by Type (2024-2034) & (US$ Million)
Table 55. Latin America Molecular Diagnostics Raw Material Revenue by Application (2018-2023) & (US$ Million)
Table 56. Latin America Molecular Diagnostics Raw Material Revenue by Application (2024-2034) & (US$ Million)
Table 57. Latin America Molecular Diagnostics Raw Material Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 58. Latin America Molecular Diagnostics Raw Material Revenue by Country (2018-2023) & (US$ Million)
Table 59. Latin America Molecular Diagnostics Raw Material Revenue by Country (2024-2034) & (US$ Million)
Table 60. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Company (2021-2023) & (US$ Million)
Table 61. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Type (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Type (2024-2034) & (US$ Million)
Table 63. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Application (2018-2023) & (US$ Million)
Table 64. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Application (2024-2034) & (US$ Million)
Table 65. Middle East and Africa Molecular Diagnostics Raw Material Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 66. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Country (2018-2023) & (US$ Million)
Table 67. Middle East and Africa Molecular Diagnostics Raw Material Revenue by Country (2024-2034) & (US$ Million)
Table 68. Thermo Fisher Company Details
Table 69. Thermo Fisher Business Overview
Table 70. Thermo Fisher Molecular Diagnostics Raw Material Product and Services
Table 71. Thermo Fisher Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Molecular Diagnostics Raw Material SWOT Analysis
Table 73. Thermo Fisher Recent Development
Table 74. Promega Company Details
Table 75. Promega Business Overview
Table 76. Promega Molecular Diagnostics Raw Material Product and Services
Table 77. Promega Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 78. Promega Molecular Diagnostics Raw Material SWOT Analysis
Table 79. Promega Recent Development
Table 80. Roche Company Details
Table 81. Roche Business Overview
Table 82. Roche Molecular Diagnostics Raw Material Product and Services
Table 83. Roche Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 84. Roche Molecular Diagnostics Raw Material SWOT Analysis
Table 85. Roche Recent Development
Table 86. Bio-Rad Company Details
Table 87. Bio-Rad Business Overview
Table 88. Bio-Rad Molecular Diagnostics Raw Material Product and Services
Table 89. Bio-Rad Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 90. Bio-Rad Molecular Diagnostics Raw Material SWOT Analysis
Table 91. Bio-Rad Recent Development
Table 92. Takara Bio Company Details
Table 93. Takara Bio Business Overview
Table 94. Takara Bio Molecular Diagnostics Raw Material Product and Services
Table 95. Takara Bio Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 96. Takara Bio Molecular Diagnostics Raw Material SWOT Analysis
Table 97. Takara Bio Recent Development
Table 98. Agilent Company Details
Table 99. Agilent Business Overview
Table 100. Agilent Molecular Diagnostics Raw Material Product and Services
Table 101. Agilent Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 102. Agilent Molecular Diagnostics Raw Material SWOT Analysis
Table 103. Agilent Recent Development
Table 104. Qiagen Company Details
Table 105. Qiagen Business Overview
Table 106. Qiagen Molecular Diagnostics Raw Material Product and Services
Table 107. Qiagen Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 108. Qiagen Molecular Diagnostics Raw Material SWOT Analysis
Table 109. Qiagen Recent Development
Table 110. Fapon Biotech Company Details
Table 111. Fapon Biotech Business Overview
Table 112. Fapon Biotech Molecular Diagnostics Raw Material Product and Services
Table 113. Fapon Biotech Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 114. Fapon Biotech Molecular Diagnostics Raw Material SWOT Analysis
Table 115. Fapon Biotech Recent Development
Table 116. TOYOBO Biotech Company Details
Table 117. TOYOBO Biotech Business Overview
Table 118. TOYOBO Biotech Molecular Diagnostics Raw Material Product and Services
Table 119. TOYOBO Biotech Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 120. TOYOBO Biotech Molecular Diagnostics Raw Material SWOT Analysis
Table 121. TOYOBO Biotech Recent Development
Table 122. Vazyme Company Details
Table 123. Vazyme Business Overview
Table 124. Vazyme Molecular Diagnostics Raw Material Product and Services
Table 125. Vazyme Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 126. Vazyme Molecular Diagnostics Raw Material SWOT Analysis
Table 127. Vazyme Recent Development
Table 128. Fapon Biotech Inc Company Details
Table 129. Fapon Biotech Inc Business Overview
Table 130. Fapon Biotech Inc Molecular Diagnostics Raw Material Product and Services
Table 131. Fapon Biotech Inc Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 132. Fapon Biotech Inc Recent Development
Table 133. New England Biolabs Company Details
Table 134. New England Biolabs Business Overview
Table 135. New England Biolabs Molecular Diagnostics Raw Material Product and Services
Table 136. New England Biolabs Molecular Diagnostics Raw Material Revenue in Molecular Diagnostics Raw Material Business (2018-2023) & (US$ Million)
Table 137. New England Biolabs Recent Development
Table 138. Molecular Diagnostics Raw Material Market Trends
Table 139. Molecular Diagnostics Raw Material Market Drivers
Table 140. Molecular Diagnostics Raw Material Market Challenges
Table 141. Molecular Diagnostics Raw Material Market Restraints
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Molecular Diagnostics Raw Material Product Picture
Figure 2. Global Molecular Diagnostics Raw Material Market Size by Type (US$ Million): 2018 VS 2024 VS 2034
Figure 3. Global Molecular Diagnostics Raw Material Market Share by Type: 2024 VS 2034
Figure 4. Reverse Transcriptase Features
Figure 5. DNA Polymerase Features
Figure 6. PCR Excipients Features
Figure 7. Other Features
Figure 8. Global Molecular Diagnostics Raw Material Market Size by Application (US$ Million): 2018 VS 2024 VS 2034
Figure 9. Global Molecular Diagnostics Raw Material Market Share by Application: 2024 VS 2034
Figure 10. Disease Diagnosis
Figure 11. Adjuvant Therapy
Figure 12. scientific Research
Figure 13. Molecular Diagnostics Raw Material Report Years Considered
Figure 14. Global Molecular Diagnostics Raw Material Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Molecular Diagnostics Raw Material Market Size 2018-2034 (US$ Million)
Figure 16. Global Molecular Diagnostics Raw Material Market Size Market Share by Region: 2024 VS 2034
Figure 17. Global Molecular Diagnostics Raw Material Revenue Market Share by Region in 2018 VS 2024
Figure 18. Global Molecular Diagnostics Raw Material Revenue Market Share Forecast by Region (2024-2034)
Figure 19. Global Top 10 Molecular Diagnostics Raw Material Countries Ranking by Market Size (US$ Million) in 2024
Figure 20. Global Molecular Diagnostics Raw Material Market Size of Top 10 Countries, 2018 VS 2024 VS 2034, (US$ Million)
Figure 21. Global Molecular Diagnostics Raw Material Market Share by Players in 2024
Figure 22. Global Top Molecular Diagnostics Raw Material Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Raw Material as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Molecular Diagnostics Raw Material Revenue in 2024
Figure 24. North America Molecular Diagnostics Raw Material Revenue Market Share by Company in 2024
Figure 25. North America Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2034)
Figure 26. North America Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2034)
Figure 27. North America Molecular Diagnostics Raw Material Revenue Share by Country (2018-2034)
Figure 28. United States Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 29. Canada Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 30. Europe Molecular Diagnostics Raw Material Revenue Market Share by Company in 2024
Figure 31. Europe Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2034)
Figure 32. Europe Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2034)
Figure 33. Europe Molecular Diagnostics Raw Material Revenue Share by Country (2018-2034)
Figure 34. Germany Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 35. France Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 36. U.K. Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 37. Italy Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 38. Russia Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 39. Asia Pacific Molecular Diagnostics Raw Material Revenue Market Share by Company in 2024
Figure 40. Asia Pacific Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2034)
Figure 41. Asia Pacific Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2034)
Figure 42. Asia Pacific Molecular Diagnostics Raw Material Revenue Share by Region (2018-2034)
Figure 43. China Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 44. Japan Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 45. South Korea Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 46. India Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 47. Australia Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 48. China Taiwan Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 49. Indonesia Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 50. Thailand Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 51. Malaysia Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 52. Latin America Molecular Diagnostics Raw Material Revenue Market Share by Company in 2024
Figure 53. Latin America Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2034)
Figure 54. Latin America Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2034)
Figure 55. Latin America Molecular Diagnostics Raw Material Revenue Share by Country (2018-2034)
Figure 56. Mexico Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 57. Brazil Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 58. Argentina Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 59. Middle East and Africa Molecular Diagnostics Raw Material Revenue Market Share by Company in 2024
Figure 60. Middle East and Africa Molecular Diagnostics Raw Material Revenue Market Share by Type (2018-2034)
Figure 61. Middle East and Africa Molecular Diagnostics Raw Material Revenue Market Share by Application (2018-2034)
Figure 62. Middle East and Africa Molecular Diagnostics Raw Material Revenue Share by Country (2018-2034)
Figure 63. Turkey Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 64. Saudi Arabia Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 65. UAE Molecular Diagnostics Raw Material Revenue (2018-2034) & (US$ Million)
Figure 66. Thermo Fisher Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 67. Promega Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 68. Roche Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 69. Bio-Rad Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 70. Takara Bio Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 71. Agilent Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 72. Qiagen Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 73. Fapon Biotech Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 74. TOYOBO Biotech Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 75. Vazyme Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 76. Fapon Biotech Inc Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 77. New England Biolabs Revenue Growth Rate in Molecular Diagnostics Raw Material Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed